AI-Powered blood test could spot 5 cancers before symptoms start
NCT ID NCT07186296
First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 39 times
Summary
This study is testing a new blood test called EXoPred that uses artificial intelligence and a laser technique called Raman spectroscopy to find signs of five different cancers (breast, colon, pancreatic, ovarian, and lung) at an early stage. Researchers will collect blood samples from 1,400 people aged 45 and older who have or are suspected to have one of these cancers. The goal is to train and validate the AI algorithm so it can accurately detect cancer and identify where in the body it started.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Albany Stratton VA Medical Center
RECRUITINGAlbany, New York, 12208, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Bronx Veterans Medical Research Foundation
NOT_YET_RECRUITINGThe Bronx, New York, 10468, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
City of Hope Duarte Cancer Center
RECRUITINGLos Angeles, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
John Hopkins University
ACTIVE_NOT_RECRUITINGBaltimore, Maryland, 21218, United States
-
KCTL
RECRUITINGLouisville, Kentucky, 40202, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lexington VA Healthcare System
RECRUITINGLexington, Kentucky, 40502, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tibor Rubin VA Medical Center
RECRUITINGLong Beach, California, 90822, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Hawaii Cancer Center
NOT_YET_RECRUITINGHonolulu, Hawaii, 96813, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
VA Hudson Valley Healthcare System
NOT_YET_RECRUITINGWappingers Falls, New York, 12590, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test that helps doctors find several types of cancer early, when they may be easier to treat.
What could go wrong
This is an early-stage study focused on developing and validating the test's algorithm. It is not yet proven to work in real-world settings, and the test may not be accurate enough for widespread use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.